{
"info": {
"nct_id": "NCT02980731",
"official_title": "Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Impact of Venetoclax on the Quality of Life of Relapsed/Refractory Subjects With Chronic Lymphocytic Leukemia (CLL) (VENICE II)",
"inclusion_criteria": "* Eastern Cooperative Oncology Group (ECOG) performance score of ≤ 2\n* Participant has relapsed/refractory disease (received at least one prior therapy)\n* Diagnosis of CLL that meets published 2008 Modified International Workshop on CLL National Cancer Institute - Working Group (IWCLL NCI-WG) Guidelines and:\n\n * has an indication for treatment according to the 2008 Modified IWCLL NCI-WG Guidelines\n * has clinically measurable disease (lymphocytosis > 5 × 10^9/L and/or palpable and measurable nodes by physical exam and/or organomegaly assessed by physical exam)\n * with or without 17p deletion or TP53 mutation\n * may have been previously treated with a prior B-cell receptor inhibitor therapy\n* Adequate bone marrow function\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
"exclusion_criteria": "* Participant has developed Richter's transformation or Prolymphocytic leukemia (PLL)\n* Participant has previously received venetoclax\n* History of active malignancies other than CLL within the past 2 years prior to first dose of venetoclax, with the exception of:\n\n * adequately treated in situ carcinoma of the cervix uteri\n * adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin\n * previous malignancy confined and surgically resected (or treated with other modalities) with curative intent\n* Active and uncontrolled autoimmune cytopenias (within 2 weeks prior to screening), including autoimmune hemolytic anemia (AIHA) or idiopathic thrombocytopenic purpura (ITP), despite low dose corticosteroids\n* Prior allogeneic stem cell transplant",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Eastern Cooperative Oncology Group (ECOG) performance score of ≤ 2",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance score of ≤ 2",
"criterion": "ECOG performance score",
"requirement": {
"requirement_type": "score",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance score of ≤ 2",
"criterion": "ECOG performance score",
"requirement": {
"requirement_type": "score",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Participant has relapsed/refractory disease (received at least one prior therapy)",
"criterions": [
{
"exact_snippets": "Participant has relapsed/refractory disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"relapsed",
"refractory"
]
}
},
{
"exact_snippets": "received at least one prior therapy",
"criterion": "prior therapy",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "therapy"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Participant has relapsed/refractory disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"relapsed",
"refractory"
]
}
},
{
"exact_snippets": "received at least one prior therapy",
"criterion": "prior therapy",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "therapy"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Diagnosis of CLL that meets published 2008 Modified International Workshop on CLL National Cancer Institute - Working Group (IWCLL NCI-WG) Guidelines and:",
"criterions": [
{
"exact_snippets": "Diagnosis of CLL",
"criterion": "chronic lymphocytic leukemia (CLL)",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
},
{
"exact_snippets": "meets published 2008 Modified International Workshop on CLL National Cancer Institute - Working Group (IWCLL NCI-WG) Guidelines",
"criterion": "IWCLL NCI-WG Guidelines compliance",
"requirement": {
"requirement_type": "compliance",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Diagnosis of CLL",
"criterion": "chronic lymphocytic leukemia (CLL)",
"requirement": {
"requirement_type": "diagnosis",
"expected_value": true
}
},
{
"exact_snippets": "meets published 2008 Modified International Workshop on CLL National Cancer Institute - Working Group (IWCLL NCI-WG) Guidelines",
"criterion": "IWCLL NCI-WG Guidelines compliance",
"requirement": {
"requirement_type": "compliance",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* has an indication for treatment according to the 2008 Modified IWCLL NCI-WG Guidelines",
"criterions": [
{
"exact_snippets": "indication for treatment according to the 2008 Modified IWCLL NCI-WG Guidelines",
"criterion": "indication for treatment",
"requirement": {
"requirement_type": "guideline",
"expected_value": "2008 Modified IWCLL NCI-WG Guidelines"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "indication for treatment according to the 2008 Modified IWCLL NCI-WG Guidelines",
"criterion": "indication for treatment",
"requirement": {
"requirement_type": "guideline",
"expected_value": "2008 Modified IWCLL NCI-WG Guidelines"
}
}
]
}
},
{
"identified_line": {
"line": "* has clinically measurable disease (lymphocytosis > 5 × 10^9/L and/or palpable and measurable nodes by physical exam and/or organomegaly assessed by physical exam)",
"criterions": [
{
"exact_snippets": "lymphocytosis > 5 × 10^9/L",
"criterion": "lymphocytosis",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 5,
"unit": "× 10^9/L"
}
}
},
{
"exact_snippets": "palpable and measurable nodes by physical exam",
"criterion": "nodes",
"requirement": {
"requirement_type": "palpability",
"expected_value": true
}
},
{
"exact_snippets": "palpable and measurable nodes by physical exam",
"criterion": "nodes",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
},
{
"exact_snippets": "organomegaly assessed by physical exam",
"criterion": "organomegaly",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "lymphocytosis > 5 × 10^9/L",
"criterion": "lymphocytosis",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">",
"value": 5,
"unit": "× 10^9/L"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "palpable and measurable nodes by physical exam",
"criterion": "nodes",
"requirement": {
"requirement_type": "palpability",
"expected_value": true
}
},
{
"exact_snippets": "palpable and measurable nodes by physical exam",
"criterion": "nodes",
"requirement": {
"requirement_type": "measurability",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "organomegaly assessed by physical exam",
"criterion": "organomegaly",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* with or without 17p deletion or TP53 mutation",
"criterions": [
{
"exact_snippets": "17p deletion",
"criterion": "17p deletion",
"requirement": {
"requirement_type": "presence",
"expected_value": {
"operator": "=",
"value": 0,
"unit": "N/A"
}
}
},
{
"exact_snippets": "17p deletion",
"criterion": "17p deletion",
"requirement": {
"requirement_type": "absence",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
}
},
{
"exact_snippets": "TP53 mutation",
"criterion": "TP53 mutation",
"requirement": {
"requirement_type": "presence",
"expected_value": {
"operator": "=",
"value": 0,
"unit": "N/A"
}
}
},
{
"exact_snippets": "TP53 mutation",
"criterion": "TP53 mutation",
"requirement": {
"requirement_type": "absence",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "17p deletion",
"criterion": "17p deletion",
"requirement": {
"requirement_type": "presence",
"expected_value": {
"operator": "=",
"value": 0,
"unit": "N/A"
}
}
},
{
"exact_snippets": "TP53 mutation",
"criterion": "TP53 mutation",
"requirement": {
"requirement_type": "presence",
"expected_value": {
"operator": "=",
"value": 0,
"unit": "N/A"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "17p deletion",
"criterion": "17p deletion",
"requirement": {
"requirement_type": "absence",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
}
},
{
"exact_snippets": "TP53 mutation",
"criterion": "TP53 mutation",
"requirement": {
"requirement_type": "absence",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
}
}
]
}
]
},
{
"and_criteria": [
{
"exact_snippets": "17p deletion",
"criterion": "17p deletion",
"requirement": {
"requirement_type": "presence",
"expected_value": {
"operator": "=",
"value": 0,
"unit": "N/A"
}
}
},
{
"exact_snippets": "TP53 mutation",
"criterion": "TP53 mutation",
"requirement": {
"requirement_type": "absence",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "17p deletion",
"criterion": "17p deletion",
"requirement": {
"requirement_type": "absence",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "N/A"
}
}
},
{
"exact_snippets": "TP53 mutation",
"criterion": "TP53 mutation",
"requirement": {
"requirement_type": "presence",
"expected_value": {
"operator": "=",
"value": 0,
"unit": "N/A"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* may have been previously treated with a prior B-cell receptor inhibitor therapy",
"criterions": [
{
"exact_snippets": "may have been previously treated with a prior B-cell receptor inhibitor therapy",
"criterion": "prior B-cell receptor inhibitor therapy",
"requirement": {
"requirement_type": "treatment history",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "may have been previously treated with a prior B-cell receptor inhibitor therapy",
"criterion": "prior B-cell receptor inhibitor therapy",
"requirement": {
"requirement_type": "treatment history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Adequate bone marrow function",
"criterions": [
{
"exact_snippets": "Adequate bone marrow function",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Adequate bone marrow function",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 99 Years",
"criterions": [
{
"exact_snippets": "maximum age of 99 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 99,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 99 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 99,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Participant has developed Richter's transformation or Prolymphocytic leukemia (PLL)",
"criterions": [
{
"exact_snippets": "Participant has developed Richter's transformation",
"criterion": "Richter's transformation",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Participant has developed ... Prolymphocytic leukemia (PLL)",
"criterion": "Prolymphocytic leukemia (PLL)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Participant has developed Richter's transformation",
"criterion": "Richter's transformation",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Participant has developed ... Prolymphocytic leukemia (PLL)",
"criterion": "Prolymphocytic leukemia (PLL)",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Participant has previously received venetoclax",
"criterions": [
{
"exact_snippets": "Participant has previously received venetoclax",
"criterion": "venetoclax treatment",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Participant has previously received venetoclax",
"criterion": "venetoclax treatment",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* History of active malignancies other than CLL within the past 2 years prior to first dose of venetoclax, with the exception of:",
"criterions": [
{
"exact_snippets": "History of active malignancies other than CLL within the past 2 years",
"criterion": "active malignancies",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of active malignancies other than CLL within the past 2 years",
"criterion": "active malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2,
"unit": "years"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of active malignancies other than CLL within the past 2 years",
"criterion": "active malignancies",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of active malignancies other than CLL within the past 2 years",
"criterion": "active malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2,
"unit": "years"
}
]
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* adequately treated in situ carcinoma of the cervix uteri",
"criterions": [
{
"exact_snippets": "adequately treated in situ carcinoma of the cervix uteri",
"criterion": "in situ carcinoma of the cervix uteri",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "adequately treated in situ carcinoma of the cervix uteri",
"criterion": "in situ carcinoma of the cervix uteri",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
}
}
},
{
"identified_line": {
"line": "* adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin",
"criterions": [
{
"exact_snippets": "adequately treated basal cell carcinoma",
"criterion": "basal cell carcinoma",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
},
{
"exact_snippets": "adequately treated ... localized squamous cell carcinoma of the skin",
"criterion": "squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
},
{
"exact_snippets": "adequately treated ... localized squamous cell carcinoma of the skin",
"criterion": "squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "localization",
"expected_value": "localized"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "adequately treated basal cell carcinoma",
"criterion": "basal cell carcinoma",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "adequately treated ... localized squamous cell carcinoma of the skin",
"criterion": "squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "treatment status",
"expected_value": "adequately treated"
}
},
{
"exact_snippets": "adequately treated ... localized squamous cell carcinoma of the skin",
"criterion": "squamous cell carcinoma of the skin",
"requirement": {
"requirement_type": "localization",
"expected_value": "localized"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* previous malignancy confined and surgically resected (or treated with other modalities) with curative intent",
"criterions": [
{
"exact_snippets": "previous malignancy confined",
"criterion": "previous malignancy",
"requirement": {
"requirement_type": "status",
"expected_value": "confined"
}
},
{
"exact_snippets": "previous malignancy ... surgically resected (or treated with other modalities) with curative intent",
"criterion": "previous malignancy",
"requirement": {
"requirement_type": "treatment",
"expected_value": "surgically resected or treated with other modalities with curative intent"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "previous malignancy confined",
"criterion": "previous malignancy",
"requirement": {
"requirement_type": "status",
"expected_value": "confined"
}
},
{
"exact_snippets": "previous malignancy ... surgically resected (or treated with other modalities) with curative intent",
"criterion": "previous malignancy",
"requirement": {
"requirement_type": "treatment",
"expected_value": "surgically resected or treated with other modalities with curative intent"
}
}
]
}
},
{
"identified_line": {
"line": "* Prior allogeneic stem cell transplant",
"criterions": [
{
"exact_snippets": "Prior allogeneic stem cell transplant",
"criterion": "allogeneic stem cell transplant",
"requirement": {
"requirement_type": "prior",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Prior allogeneic stem cell transplant",
"criterion": "allogeneic stem cell transplant",
"requirement": {
"requirement_type": "prior",
"expected_value": true
}
}
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"identified_line": {
"line": "* Active and uncontrolled autoimmune cytopenias (within 2 weeks prior to screening), including autoimmune hemolytic anemia (AIHA) or idiopathic thrombocytopenic purpura (ITP), despite low dose corticosteroids",
"criterions": [
{
"exact_snippets": "Active and uncontrolled autoimmune cytopenias (within 2 weeks prior to screening)",
"criterion": "autoimmune cytopenias",
"requirement": {
"requirement_type": "activity",
"expected_value": "active"
}
},
{
"exact_snippets": "Active and uncontrolled autoimmune cytopenias (within 2 weeks prior to screening)",
"criterion": "autoimmune cytopenias",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "Active and uncontrolled autoimmune cytopenias (within 2 weeks prior to screening)",
"criterion": "autoimmune cytopenias",
"requirement": {
"requirement_type": "time frame",
"expected_value": "within 2 weeks prior to screening"
}
},
{
"exact_snippets": "autoimmune hemolytic anemia (AIHA)",
"criterion": "autoimmune hemolytic anemia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "idiopathic thrombocytopenic purpura (ITP)",
"criterion": "idiopathic thrombocytopenic purpura",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "despite low dose corticosteroids",
"criterion": "response to corticosteroids",
"requirement": {
"requirement_type": "response",
"expected_value": "despite low dose corticosteroids"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}